ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study.

Xianhua Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.